Description of Collaborative Activity: |
The National Institutes of Health (NIH) and the Food and Drug Administration (FDA) Biomarkers Working Group is a peer-reviewed, open-access research platform where those engaged in biomarker research can turn for information on the latest advances in the application of biomarkers toward the discovery of new knowledge, and toward the clinical translation of that knowledge. BIOMARKERS Group has held many face-to-face scientific meetings on a wide variety of biomarker-related topics including the use of biomarkers in early clinical development and the validation and qualification of biomarkers, including for prevention, screening, diagnosis, and treatment purposes. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
